我要投票 三金SANJIN在口气清新剂行业中的票数:702
· 外 推 电 报 ·
2025-08-24 13:10:36 星期日

【三金SANJIN是哪个国家的品牌?】

三金SANJIN是什么牌子?「三金SANJIN」是 桂林三金药业股份有限公司 旗下著名品牌。该品牌发源于广西,由创始人邹节明在1994期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力三金SANJIN品牌出海!将品牌入驻外推网,定制三金SANJIN品牌推广信息,可以显著提高三金SANJIN产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

桂林三金药业股份有限公司是三金集团的核心企业,主营中成药、天然药物的研发和生产,是国内较早生产现代中药制剂的厂家之一,也是广西医药龙头企业。1985年以来,桂林三金坚持改革创新,依靠科技进步和科学管理,从一个名不见经传的中药作坊小厂蜕变成为全国知名的现代中药企业。

三金作为区内外知名的高新技术企业,建有国家认定的企业技术中心、博士后科研工作站及广西中药产业化工程院等创新平台。多年来,一直致力推进和实施中药产业现代化规划,积极培养、提高企业的自主创新能力。目前公司的特色中药新药均由企业技术中心主导研制。目前,三金拥有200多个注册品种和13个药品剂型,拥有桂林西瓜霜、西瓜霜润喉片、三金片、脑脉泰胶囊等自主开发的特色品种42种。经过多年努力,三金在咽喉、口腔用药和泌尿系统用药方面已形成较强的专业和市场优势,代表产品三金西瓜霜系列、三金片。“三金”牌产品已行销海内外,并享有良好声誉。

2009年7月,桂林三金以高成长、高效益的崭新面貌,成功进入资本市场,迎来企业高速发展的新阶段。近年来,为积极响应桂林市委、市政府“向西发展,再造一个新桂林”的号召,也为解决企业生产基地及仓储设施分散与企业快速发展之间的矛盾,三金启动了“三金现代中药产业化技术改造工程”的建设。目前,该项目一期已经正式投产并实现了主要生产线的整体搬迁。

面对未来,三金将秉承“创新推动医药进步”的企业使命和“敢为先”企业精神,实施以中药制药为主体,致力发展生物制药和大健康产业的”一体两翼”发展战略,视质量、信誉为企业第一生命,突破创新,不断增强三金的竞争实力,锐意进取,以发展报国、回报投资者,以打造中国知名医药制造集团为目标,推动中药产业现代化、国际化!


英文翻译:Guilin Sanjin Pharmaceutical Co., Ltd. is the core enterprise of Sanjin group, which is mainly engaged in the research and development and production of Chinese patent medicine and natural medicine. It is one of the earliest manufacturers of modern Chinese medicine preparations in China, and also the leading enterprise of Guangxi medicine. Since 1985, Guilin Sanjin has persisted in reform and innovation, relying on scientific and technological progress and scientific management, and has transformed from an unknown small traditional Chinese medicine workshop into a well-known modern Chinese medicine enterprise in China. As a well-known high-tech enterprise inside and outside the zone, Sanjin has established a national recognized enterprise technology center, postdoctoral research workstation, Guangxi Institute of traditional Chinese medicine industrialization and other innovation platforms. Over the years, we have been committed to promoting and implementing the modernization plan of traditional Chinese medicine industry, and actively cultivating and improving the independent innovation ability of enterprises. At present, the company's characteristic new Chinese medicine is mainly developed by the enterprise technology center. At present, Sanjin has more than 200 registered varieties and 13 pharmaceutical dosage forms, and 42 self-developed characteristic varieties such as Guilin Watermelon cream, watermelon cream throat moistening tablet, Sanjin tablet, Naomaitai Capsule, etc. After years of efforts, Sanjin has formed strong professional and market advantages in throat, oral medicine and urinary system medicine, representing Sanjin watermelon cream series and Sanjin tablets. "Three gold" brand products have been sold at home and abroad, and enjoy a good reputation. In July 2009, Guilin Sanjin successfully entered the capital market and ushered in a new stage of rapid development of enterprises with a new look of high growth and high efficiency. In recent years, in order to actively respond to the call of Guilin municipal Party committee and municipal government to "develop to the West and rebuild a new Guilin", and to solve the contradiction between the scattered production base and storage facilities of enterprises and the rapid development of enterprises, Sanjin has launched the construction of "Sanjin modern Chinese medicine industrialization technology transformation project". At present, the first phase of the project has been officially put into operation and the overall relocation of the main production lines has been realized. In the future, Sanjin will adhere to the enterprise mission of "innovation promotes pharmaceutical progress" and the enterprise spirit of "dare to be the first", implement the development strategy of "one body and two wings" with traditional Chinese medicine as the main body, devote to the development of biopharmaceutical and big health industry, regard quality and reputation as the life of the enterprise, break through innovation, continuously enhance the competitiveness of Sanjin, forge ahead, serve the country and return with development Newspaper investors, with the goal of building a well-known Chinese pharmaceutical manufacturing group, to promote the modernization and internationalization of traditional Chinese medicine industry!

本文链接: https://www.waitui.com/brand/7e6028fbc.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

澳大利亚将加快住房建设以应对持续危机

澳大利亚政府正计划推出一系列措施以加快房屋建设,因为该国仍在努力应对一场持续多年的全国性住房危机。根据周六的一份声明,政府将立即采取的措施包括加快对超过 26000 套新住宅的评估,并暂停进一步修改建筑法规以加快房屋审批。政府计划利用人工智能来帮助实施这些变革。住房部长克莱尔·奥尼尔在声明中表示:“在这个国家建房太难了。在一场持续数十年的住房危机中,我们希望建筑商能建造未来高品质的住宅,而不是琢磨如何应对又一套规则。”(新浪财经)

2小时前

央行公开市场下周将有20770亿元逆回购到期

Wind数据显示,下周央行公开市场将有20770亿元逆回购到期,其中下周一至下周五分别到期2665亿元、5803亿元、6160亿元、2530亿元、3612亿元。此外,下周二将有3000亿元MLF到期,下周五将有5000亿元6个月期买断式逆回购到期、4000亿元3个月期买断式逆回购到期。(证券时报)

2小时前

英国央行行长贝利:英国面临提高潜在增长率的挑战

英国央行行长安德鲁・贝利表示,只要劳动力参与率持续低迷,英国提高经济潜在增长率就将面临 “严峻挑战”。贝利在怀俄明州美联储杰克逊霍尔年会上对各国央行官员表示,英国劳动力市场的问题已不再是失业,而是劳动力参与率。除非更多英国人重新加入劳动力市场,否则必须 “更加强调生产率增长” 以提振经济。(新浪财经)

2小时前

可口可乐据悉考虑出售旗下英国咖啡连锁店Costa

据知情人士称,可口可乐已聘请投行帮助评估出售旗下英国咖啡连锁店Costa Coffee的可能性。这家总部位于亚特兰大的软饮料巨头已要求投行Lazard评估选项并评估对其2018年以39亿英镑(53亿美元)收购的这项业务的兴趣。据悉,可口可乐已与包括私募股权公司在内的少数潜在竞标者进行了初步接洽。消息人士称,目前不能确保达成交易,可口可乐最终仍可能决定不进行出售。(新浪财经)

2小时前

今年前7个月我国机械工业保持增长态势

记者从中国机械工业联合会获悉,今年以来,我国机械工业生产及投资保持增长态势。最新数据显示,今年1至7月份,机械工业主要涉及的五个大类行业增加值同比保持增长趋势。通用设备制造业增长8.3%;专用设备制造业增长3.8%;汽车制造业增长10.9%;电气机械和器材制造业增长11.9%;仪器仪表制造业增长7.1%。(央视新闻)

2小时前

本页详细列出关于三金SANJIN的品牌信息,含品牌所属公司介绍,三金SANJIN所处行业的品牌地位及优势。
咨询